Search
for
Sort by
Research 30 of 355
- Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations
- A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Mitigation of epidermal growth factor receptor inhibitor-induced side effects utilizing melanin and vascular-specific lasers: A case report series
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses: a large original study of a general COVID-19 centers from Iran
- Treatment of acne with intermittent isotretinoin, cohort study
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Persistent Facial and Chest Papular and Pustular Eruption in a Stem Cell Transplant Patient
- PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors)
- A case report on individualized homoeopathic management of acne with kalium bromatum
- Pyodermatitis vegetans associated with multiple myeloma
- Eosinophilic Pustular Folliculitis Mimicking Varicella: A Diagnostic Challenge in an Adolescent Patient